Janicke D M, Mangione A, Schultz R W, Jusko W J
Antimicrob Agents Chemother. 1981 Nov;20(5):590-4. doi: 10.1128/AAC.20.5.590.
The pharmacokinetics of a single 1-g intravenous dose of mezlocillin were examined in six functionally anephric patients undergoing hemodialysis. Hemodialysis clearance calculated by plasma extraction ratios across the dialyzer membrane and by dialysis fluid agree well, averaging 26 and 32 ml/min. Dialyzer extraction ratios averaged 0.16 +/- 0.07, and 23.3 +/- 9.6% of the dose was measured in the dialysate. Plasma clearances (104 +/- 45 ml/min) and steady-state volumes of distribution (0.22 +/- 0.07 liter/kg) of mezlocillin showed good agreement with literature values. The nonrenal clearance (4.25 +/- 2.30 liters/h per 1.73 m2) of mezlocillin was appreciable. Drug loss by hemodialysis is small and should have little effect on therapeutic dosage needs.
对6名接受血液透析的功能性无肾患者静脉注射1克美洛西林后的药代动力学进行了研究。通过透析器膜的血浆提取率和透析液计算出的血液透析清除率吻合良好,平均分别为26和32毫升/分钟。透析器提取率平均为0.16±0.07,在透析液中测得剂量的23.3±9.6%。美洛西林的血浆清除率(104±45毫升/分钟)和稳态分布容积(0.22±0.07升/千克)与文献值吻合良好。美洛西林的非肾清除率(每1.73平方米4.25±2.30升/小时)相当可观。血液透析造成的药物损失较小,对治疗剂量需求影响不大。